AI Article Synopsis

  • The study aimed to evaluate vitamin D levels in children with immune thrombocytopenic purpura (ITP), revealing a high prevalence of vitamin D deficiency among both newly diagnosed and chronic cases.
  • Out of 21 patients, 11 with new ITP and 7 with chronic ITP were found to have vitamin D levels below the normal range, while only 3 newly diagnosed patients had sufficient levels.
  • The research suggests the potential benefit of vitamin D supplementation in ITP patients and calls for a randomized controlled trial to explore its immune-modulating effects.

Article Abstract

The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective study) patients. VD deficiency (values <75 nmol/L) was detected in 11 patients with newly diagnosed ITP, and seven patients with chronic ITP. Only three patients with newly diagnosed, and none with chronic ITP had normal VD values. Newly diagnosed ITP patients had statistically significantly higher values (P <.044) of VD than the patients with chronic type of ITP. Platelets values did not follow VD level. VD deficiency is very common in children with either newly diagnosed or chronic ITP form. Therefore there is a utility supplementing VD in these patients. To investigate the role of VD as an immune modulating drug for patients with ITP, a prospective randomized placebo-controlled trial needs to be performed.

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2016.04.020DOI Listing

Publication Analysis

Top Keywords

newly diagnosed
8
serum vitamin
4
vitamin levels
4
levels children
4
children newly
4
diagnosed chronic
4
chronic immune
4
immune thrombocytopenia
4
thrombocytopenia primary
4
primary objective
4

Similar Publications

Objective: In the Diabetes Virus Detection and Intervention trial, antiviral treatment with pleconaril and ribavirin decreased the decline, compared with placebo, in endogenous C-peptide 1 year after diagnosis of type 1 diabetes (T1D) in children and adolescents. This article reports the results 2 and 3 years after diagnosis.

Research Design And Methods: This was a multicenter, randomized, placebo-controlled (1:1) trial of 96 children and adolescents aged 6-15.

View Article and Find Full Text PDF

Background: Multidisciplinary teams (MDTs) are essential for cancer care but are resource-intensive. Decision-making processes within MDTs, while critical, contribute to increased healthcare costs due to the need for specialist time and coordination. The recent emergence of large language models (LLMs) offers the potential to improve the efficiency and accuracy of clinical decision-making processes, potentially reducing costs associated with traditional MDT models.

View Article and Find Full Text PDF

Vacuolar myopathy with monoclonal gammopathy and stiffness (VAMMGAS).

Eur J Neurol

January 2025

Groupe Hospitalier Pitié-Salpêtrière, Institut de Myologie, AP-HP, Sorbonne Université, Paris, France.

Background: Monoclonal gammopathy (MG) has been reported in association with numerous neurological disorders but the spectrum of MG-associated myopathies remains poorly described.

Objective: To report a newly acquired myopathy associated with MG.

Methods: Three adult patients with the same phenotype from two French referral centers were prospectively analyzed.

View Article and Find Full Text PDF

Background: There are no studies investigating missed opportunities for earlier diagnosis in newly/recently detected Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease in the region of Bihar, India.

Methods: This study is a single-center cross-sectional study undertaken at the Research Centre for Diabetes Hypertension and Obesity, Samastipur, Bihar, India. The study collected data from newly/recently diagnosed persons with T2DM.

View Article and Find Full Text PDF

Background: The strong association between type 2 diabetes mellitus (T2DM) and fatty liver is well known, and its nomenclature has even recently changed to metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy MASLD patients are frequently overlooked and maltreated, especially in Bangladesh. In this present study, we tried to correlate T2DM burden in apparently healthy, incidentally diagnosed fatty liver patients on ultrasound.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!